Position in IBRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$50,376
+$6,243 QoQ
Shares Held
5,754
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#315
of 403 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $3,299,056 across 37 Biotechnology names. IBRX ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GALT |
Galectin Therapeutics Inc
|
240,427 | $1,115,581 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,199 | $954,815 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,300 | $545,264 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
48,100 | $124,579 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
1,269 | $69,718 | |
| 7 | IBRX |
ImmunityBio, Inc.
This page
|
5,754 | $50,376 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 |
All Filings in IBRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,376 | 5,754 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $44,133 | 5,754 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,677 | 847 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,083 | 847 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,236 | 847 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $2,549 | 847 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,728 | 1,847 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,150 | 847 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,353 | 847 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||